The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Sun, May 29, 2022 | 18:08
-------------------------
'RNL Bio smuggled out stem cells'
Posted : 2013-01-03 19:40
Updated : 2013-01-03 19:40
Print Preview
Font Size Up
Font Size Down
By Yun Suh-young

Stem cell research company RNL Bio faced allegations Thursday that it "smuggled" stem cells and related equipment overseas.

According to multiple sources, the company sent 15.5 billion won worth of stem cells to hospitals in China and Japan on 860 different occasions from November 2008 through July 2012 without reporting the shipments to the Korea Customs Service (KCS).

The company also allegedly smuggled out stem cell incubating batches worth 1.1 billion won to a Chinese corporation through a merchant.

"The fact that the company has not reported the items to customs is true. The case has now been referred to the prosecution for further investigation," said an official from the KCS.

Under the Customs Law, if a person sends items for business use overseas, they must report them to the customs.

RNL Bio is also embroiled in controversy over introducing Korean patients to Japanese hospitals for stem cell therapy, which is highly restricted here.

The company was criticized for exposing patients to potential risks arising from the treatment. Under the Korean Pharmaceutical Law, only stem cell treatment that has received approval after clinical testing is acceptable for use. In Japan, however, doctors are free to conduct operations with stem cells they have extracted from patients without approval from the health authorities.

Prosecutors had been investigating the case after the Ministry of Health and Welfare referred the company to it for violating the Pharmaceutical Law in January last year. However, they halted the investigation in June following the company's filing of a complaint with the Constitutional Court.

RNL Bio claimed the current law requiring researchers to receive certification for stem cell treatments after undergoing three rounds of clinical testing was a violation of the right to conduct research.

The prosecution plans to restart its investigation dependent on the ruling from the Constitutional Court.

The company did not give an immediate response to whether the allegations were true, but said it would release a public statement today.

Emailysy@koreatimes.co.kr Article ListMore articles by this reporter
 
  • Korean Mental Health: Stranger Things
  • Dutch Korean artist's project: The Mother Mountain Institute of Sara Sejin Chang
  • Why Mario Outlet founder keeps buying houses of former presidents
  • S. Korea's new COVID-19 cases below 20,000 for 3rd day as pandemic slows
  • Union agress to resume late-night subway services in Seoul starting next month
  • Regional banks' declining offline business casts doubts over relocation plan of Seoul firms
  • 'Russia needs huge financial resources for military operations'
  • KOICA launches interactive town in metaverse for overseas volunteer program
  • Former rhythmic gymnast Son Yeon-jae to wed in August
  • Uvalde school police chief faulted in shooting response
  • Korean films make splash at Cannes Film Festival Korean films make splash at Cannes Film Festival
  • From BTS to TWICE's Nayeon, K-pop hotshots prepare June releases From BTS to TWICE's Nayeon, K-pop hotshots prepare June releases
  • How did BTS become beacon of diversity and inclusion? How did BTS become beacon of diversity and inclusion?
  • K-pop band BTS and Biden to meet to discuss Asian inclusion, discrimination K-pop band BTS and Biden to meet to discuss Asian inclusion, discrimination
  • For new cultural policy for hallyu For new cultural policy for hallyu
DARKROOM
  • 75th Cannes Film Festival

    75th Cannes Film Festival

  • People in North Korea trapped in famine and pandemic

    People in North Korea trapped in famine and pandemic

  • 2022 Pulitzer Prize: Bearing witness to history

    2022 Pulitzer Prize: Bearing witness to history

  • Worsening drought puts millions at risk

    Worsening drought puts millions at risk

  • Our children deserve the best

    Our children deserve the best

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group